EUVIMEDEUVIMED entdecken
Crossref

Genomic and functional characterization of Limosilactobacillus fermentum DX2034 identifies a probiotic candidate with TLR2-associated anti-adipogenic activity

Do-Won Park iD, Ji Hyung Kim, Do-Young Park iD

Letters in Applied Microbiology · 2026

DOI: 10.1093/lambio/ovag080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Letters in Applied Microbiology, 2026. Verfasst von Do-Won Park und 2 weiteren Autor:innen. Beteiligte Einrichtung: Microbiome Research Institute, Dx&Vx Co., Ltd., Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Probiotics, Adipogenesis, Toll-Like Receptor 2, Limosilactobacillus fermentum. Die Arbeit nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Limosilactobacillus fermentum is a promising probiotic species with reported benefits for gastrointestinal health and host metabolism. In this study, a novel L. fermentum strain, DX2034, isolated from the feces of a healthy Korean infant, was characterized through phenotypic and genomic analyses, and its anti-adipogenic activity was evaluated in differentiated 3T3-L1 adipocytes. DX2034 exhibited high tolerance to simulated gastric and bile conditions and showed stronger adhesion to Caco-2 cells than the reference strain L. fermentum CECT5716. The strain showed no hemolytic activity and was susceptible to most tested antibiotics. Whole-genome sequencing revealed a single circular chromosome of 2 160 171 bp with no acquired antibiotic resistance genes, virulence-associated factors, or concerning secondary metabolite biosynthetic gene clusters. Comparative genomic analysis identified genomic regions showing low similarity to reference strains, including a putative glycosyltransferase-associated locus, and genes associated with stress adaptation, gastrointestinal persistence, surface modification, and quorum sensing. Heat-killed DX2034 significantly reduced lipid accumulation, intracellular triglyceride content, and expression of adipogenesis-related genes, including C/EBPα, PPARγ, FABP4, LPL, and FASN. These effects were attenuated by the TLR2 inhibitor C29, suggesting involvement of TLR2-associated signaling. Collectively, DX2034 exhibits favorable probiotic-associated characteristics, genomic safety, and TLR2-associated anti-adipogenic activity, supporting its potential as a functional probiotic or postbiotic candidate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsAdipogenesisToll-Like Receptor 2Limosilactobacillus fermentumAnimalsHumansMice3T3-L1 CellsCaco-2 CellsFecesAdipocytesGenome, BacterialBacterial AdhesionGenomics

Stichwörter der Autor:innen

Limosilactobacillus fermentumTLR2anti-adipogenic activitypostbioticprobiotic

Substanzen

Toll-Like Receptor 2TLR2 protein, human

Autor:innen und Institutionen

  • Microbiome Research Institute, Dx&Vx Co., Ltd., Seoul, Republic of Korea.
  • Department of Food Science and Biotechnology, Gachon University, Seongnam, Republic of Korea.

ORCID-Profile: Do-Won Park, Do-Young Park

Zitieren

APA

Park, D. W., Kim, J. H., & Park, D. Y. (2026). Genomic and functional characterization of Limosilactobacillus fermentum DX2034 identifies a probiotic candidate with TLR2-associated anti-adipogenic activity. Letters in Applied Microbiology. https://doi.org/10.1093/lambio/ovag080

Vancouver

Park DW, Kim JH, Park DY. Genomic and functional characterization of Limosilactobacillus fermentum DX2034 identifies a probiotic candidate with TLR2-associated anti-adipogenic activity. Letters in Applied Microbiology. 2026. doi:10.1093/lambio/ovag080

BibTeX
@article{Park2026,
  author = {Park, Do-Won and Kim, Ji Hyung and Park, Do-Young},
  title = {Genomic and functional characterization of Limosilactobacillus fermentum DX2034 identifies a probiotic candidate with TLR2-associated anti-adipogenic activity},
  journal = {Letters in Applied Microbiology},
  year = {2026},
  doi = {10.1093/lambio/ovag080}
}
Kostenlos starten →